Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies

Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
Haematologica Early view Jan 16, 2025 https://doi.org/10.3324/haematol.2024.286593

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.286593
 
Published
2025-01-16
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
130
PDF Downloads
42

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online